Manuella R. Andrade

Manuella R. Andrade

Auto-generated profile, based on publicly available information

Manuella R. Andrade

Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
SNShannon Niedermeyer
Shannon Niedermeyer
XYXin Yun
Xin Yun
MTMarielena Trujillo
Marielena Trujillo
HJHaiyang Jiang
Haiyang Jiang
MAManuella R. Andrade
Manuella R. Andrade
LSLarissa Shimoda
Larissa Shimoda
Pulmonary arterial smooth muscle cells (PASMCs) are integral to pulmonary vascular remodeling, a characteristic of pulmonary arterial hypertension (PAH). PASMCs isolated from robust animal models of disease demonstrate enhanced proliferation and migration, pathological functions associated with increased abundance of the membrane protein aquaporin 1 (AQP1). We present evidence of a novel interaction between the proteolytic enzyme caspase-3 and AQP1, which may control AQP1 abundance. These data suggest a potential new target for novel PAH therapies.

10 November 2026 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
MAManuella R. Andrade
Manuella R. Andrade
XYXin Yun
Xin Yun
MCMichael P. Croglio
Michael P. Croglio
SNShannon Niedermeyer
Shannon Niedermeyer
HJHaiyang Jiang
Haiyang Jiang
LSLarissa Shimoda
Larissa Shimoda
Pulmonary hypertension (PH) is characterized by vascular remodeling driven in part by apoptosis-resistant pulmonary arterial smooth muscle cells (PASMCs). Na + /H + exchanger isoform 1 (NHE1) regulates intracellular pH and plasma membrane cytoskeleton anchoring, but the role of NHE1 in PASMC apoptosis remains unclear. PASMCs were isolated from distal pulmonary arteries from control and Sugen/Hypoxia (SuHx) rats, a model of PH. NHE activity was measured via the ammonium pulse technique, protein via immunoblot, and apoptosis via Hoechst staining, Caspase-Glo ® 3/7 Assay System and Annexin V/ propidium iodide immunofluorescence. NHE activity and NHE1 surface expression were increased in SuHx PASMCs compared to controls. Despite increased endoplasmic reticulum stress at baseline, SuHx PASMCs were resistant to apoptosis following hydrogen peroxide (H 2 O 2 ) challenge. Inhibition of NHE activity with ethyl-isopropyl amiloride (EIPA) and NHE1 silencing with siRNA restored apoptosis in SuHx PASMCs. Conversely, NHE1 overexpression in control PASMCs conferred apoptosis resistance. Expression of mutant NHE1 constructs lacking ion translocation or ezrin binding also reduced H 2 O 2 -induced apoptosis. Mechanistically, H 2 O 2 increased p38 phosphorylation (p-p38) in PASMCs from control, but not SuHx, rats, indicating impaired activation of this pro-apoptotic pathway. NHE1 suppression via EIPA or siRNA restored p-p38 in SuHx PASMCs, while overexpression of NHE1 (wild-type or mutants) suppressed p-p38 following apoptotic stimulation. Inhibition of p-p38 with SB203580 prevented the pro-apoptotic effect of EIPA, validating a role for p-p38 signaling in NHE1-mediated apoptosis resistance in SuHx PASMCs. These findings identify NHE1 as necessary and sufficient for PASMC apoptosis resistance in PH, by a mechanism involving suppression of p-p38.